75 results on '"Yao, J.C."'
Search Results
2. LBA25 FRESCO-2: A global phase III multiregional clinical trial (MRCT) evaluating the efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer
3. Analyse finale de la survie globale dans l’étude de phase 3 NETTER-1 du Lu-DOTATATE chez les patients atteints de tumeurs neuroendocrines de l’intestin moyen
4. 1102P The phase III NETTER-1 study of 177Lu-DOTATATE in patients with midgut neuroendocrine tumours: Further survival analyses
5. 403MO Atezolizumab in combination with bevacizumab for patients with unresectable/metastatic anal cancer
6. Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
7. Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors
8. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
9. Randomized, open-label, perioperative phase II study evaluating nivolumab alone versus nivolumab plus ipilimumab in patients with resectable HCC
10. A New Version of KKM Theorem with Geodesic Convex Hull with an Application on Hadamard Manifold
11. Impact of liver tumor burden on therapeutic effect of 177Lu-dotatate treatment in NETTER-1 study
12. Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)
13. Novel composite nanomaterials with superior thermal and pressure stability for potential LED applications
14. PS04.05 ElevatION NET 201:Ph II Study of PDR001 in Metastatic, Well Differentiated NET of Pancreatic/GI/Thoracic Origin or Poorly Differentiated GEP NEC
15. Strong red emission and catalytic properties of ZnO by adding Eu2O3 shell
16. A Phase II study of sorafenib and yttrium-90 glass microspheres for advanced hepatocellular carcinoma, BCLC stage C
17. Efficacy of everolimus plus octreotide LAR in patients with advanced neuroendocrine tumor and carcinoid syndrome: final overall survival from the randomized, placebo-controlled phase 3 RADIANT-2 study
18. Clinical, pathological, and demographic factors associated with development of recurrences after surgical resection in elderly patients with neuroendocrine tumors
19. Approximate Cayley transform methods for inverse eigenvalue problems and convergence analysis
20. A randomized, open-label, phase 2 study of everolimus in combination with pasireotide LAR or everolimus alone in advanced, well-differentiated, progressive pancreatic neuroendocrine tumors: COOPERATE-2 trial
21. 177 Lu-Dotatate améliore significativement la survie sans progression des patients atteints de tumeurs neuroendocrines métastatiques progressives de l’intestin moyen : résultats de l’essai de phase III NETTER-1
22. A new incremental constraint projection method for solving monotone variational inequalities
23. 134O RADIANT-4: Efficacy and safety of everolimus in advanced, nonfunctional neuroendocrine tumors (NET) of the lung or gastrointestinal (GI) tract
24. Error bound and well-posedness with respect to an admissible function
25. An iterative algorithm for solving generalized variational inequality problems and fixed point problems
26. Radiation Therapy for High-Grade Neuroendocrine Carcinoma of the Rectum and Anal Canal
27. Everolimus (Eve) for the Treatment of Advanced Pancreatic Neuroendocrine Tumors (Pnet): Final Overall Survival (Os) Results of a Randomized, Double-Blind, Placebo (Pbo)-Controlled, Multicenter Phase III Trial (Radiant-3)
28. A unified hybrid iterative method for hierarchical minimization problems
29. A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer
30. Quality of life, resource utilisation and health economics assessment in advanced neuroendocrine tumours: a systematic review
31. Targeted Treatment of Nets
32. The Vegf Pathway in Patients with Pancreatic Neuroendocrine Tumors: Efficacy of Everolimus by Baseline Marker Level, and Prognostic and Predictive Effect Analyses from Radiant-3
33. 6573 POSTER Effect of Everolimus Treatment on Markers of Angiogenesis in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET) – Results From the Phase III RADIANT-3 Study
34. 6561 POSTER Updated Survival and Safety Data From RADIANT-3 – a Randomized, Double-blind, Placebo-controlled, Multicenter, Phase III Trial of Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumours (pNET)
35. 6566 POSTER Updated Safety and Efficacy Results From RADIANT-2 – a Randomized, Double-blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Pts With Advanced Neuroendocrine Tumours (NET)
36. 6564 POSTER Correlation of PFS With Early Response of Chromogranin A and 5-hydroxyindoleacetic Acid Levels in Pts With Advanced Neuroendocrine Tumours: Phase III RADIANT-2 Study Results
37. Ni–Al–O diffusion barrier layer for high-κ metal-oxide-semiconductor capacitor
38. Implicit iterative algorithms for asymptotically nonexpansive mappings in the intermediate sense and Lipschitz-continuous monotone mappings
39. Pseudo-Lipschitz property of linear semi-infinite vector optimization problems
40. On relaxed viscosity iterative methods for variational inequalities in Banach spaces
41. Strong convergence theorems for maximal monotone operators in Banach spaces
42. On generalized variational-like inequalities with generalized monotone multivalued mappings
43. Degree theory for generalized variational inequalities and applications
44. Existence of vector mixed variational inequalities in Banach spaces
45. Cauchy–Dirichlet problem for second-order hyperbolic equations in cylinders with non-smooth base
46. Well-posedness of generalized mixed variational inequalities, inclusion problems and fixed-point problems
47. Solving variational inequalities involving nonexpansive type mappings
48. Application of a coincidence index to some classes of impulsive control systems
49. An implicit iterative scheme for monotone variational inequalities and fixed point problems
50. On the solution existence of implicit quasivariational inequalities with discontinuous multifunctions
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.